MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price traded up 7.7% during trading on Thursday . The company traded as high as C$0.08 and last traded at C$0.07. 713,415 shares were traded during mid-day trading, an increase of 107% from the average session volume of 344,238 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The firm has a market capitalization of C$26.72 million, a PE ratio of -1.63 and a beta of 0.88. The company has a quick ratio of 3.10, a current ratio of 3.11 and a debt-to-equity ratio of 5.90. The company’s 50-day simple moving average is C$0.07 and its 200 day simple moving average is C$0.07.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Recommended Stories
- Five stocks we like better than MediPharm Labs
- Consumer Discretionary Stocks Explained
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- What is Insider Trading? What You Can Learn from Insider Trading
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- What is diluted earnings per share (Diluted EPS)?
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
